This joint NC3Rs/EPAA webinar will provide an overview of two recent publications on chronic toxicity studies, and discuss key results and recommendations. In particular, a proposed weight-of-evidence model will be highlighted, with case studies explaining the potential decision processes. Additionally, 3Rs opportunities identified within the dataset, including group sizes and the use of recovery animals, will be presented.
This webinar is relevant for regulatory and industry scientists working with mAbs and other drug modalities. It will be of interest to professionals who would like to explore new approaches for chronic toxicity studies and opportunities to apply the 3Rs. There will be a panel discussion at the end of the webinar, during which audience members will be able to ask questions.
- Publication date
- 13 March 2023
- Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs